75岁及以上BRCA1和BRCA2突变女性的临床特征与结局
回顾性研究分析1995至2015年美国加州医疗系统中1189名BRCA突变女性,其中69名活至75岁及以上。多数女性基因检测时年龄较大且已有BRCA相关癌症史,部分高龄女性仍接受降低风险手术;胰腺癌是随访期间最常见的新发癌症。
要点
- 69名75岁及以上BRCA突变女性中,72%有乳腺癌史,39%有卵巢癌史。
- 无乳腺癌史的19名女性中3名(16%)在阳性基因检测后接受降低风险乳房切除术(RRM)。
- 卵巢仍在的30名女性中14名(47%)接受降低风险输卵管卵巢切除术(RRSO),其中6名手术时年龄70岁及以上。
核心结论
- 多数活过75岁的BRCA突变女性在较大年龄获得基因检测结果,且已有BRCA相关癌症史;高龄女性仍继续接受监测和降低风险手术;胰腺癌是老年BRCA突变携带者中最常见的新发癌症。
研究设计与样本
- 回顾性研究,从1995至2015年美国加州医疗系统中1189名BRCA突变女性数据库里识别出69名活至75岁及以上的参与者,记录人口学和临床特征、癌症史及采用的降低风险策略,采用描述性和双变量分析。
主要发现
- 队列研究入组时中位年龄78岁(IQR:76-84),基因检测时中位年龄73岁(IQR:68-79)。
- 50名(72%)女性有乳腺癌史,27名(39%)有卵巢癌史。
- 无乳腺癌史的19名女性中3名(16%)在阳性基因检测后选择接受降低风险乳房切除术(RRM)。
- 卵巢仍在的30名女性中14名(47%)接受降低风险输卵管卵巢切除术(RRSO),其中6名手术时年龄70岁及以上。
- 队列中4名(6%)女性在检测后发生BRCA相关癌症,1名乳腺癌,3名胰腺癌。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Describe clinical characteristics and risk reducing strategies utilized among women with a BRCA mutation who lived to age 75 and above. METHODS: A retrospective study of women with BRCA mutations identified from 1995 to 2015 in a California health care system. From a database of 1189 women, 69 participants were identified who lived to age 75 or older. Demographic and clinical characteristics were recorded, as well as cancer history and risk-reducing strategies utilized. Descriptive and bivariate analyses were used to analyze the cohort. RESULTS: The median age of the cohort at study entry was 78 (IQR: 76-84) and the median age at time of genetic testing was 73 (IQR 68-79). Fifty (72%) women had a prior history of breast cancer and 27 (39%) had a history of ovarian cancer. Three of 19 (16%) women with no history of breast cancer elected to undergo a risk-reducing mastectomy (RRM) after their positive genetic test. Among 30 women with ovaries still in place, 14 (47%) underwent a risk-reducing salpingo-oophorectomy (RRSO); six were age 70 or older at the time of surgery. Four (6%) women in the cohort developed BRCA-related cancer after testing, one developed breast cancer and three developed pancreatic cancer. CONCLUSIONS: Most women with BRCA mutations surviving beyond age 75 received their genetic test result at an older age and had a history of BRCA-related cancer. Women continued surveillance and risk reducing surgeries at an older age. Pancreatic cancer was the most common new cancer diagnosed in older BRCA mutation carriers.
引用
- Salyer C, Kobelka C, Barrie A, et al. Clinical characteristics and outcomes in elderly women with BRCA1 and BRCA2 mutations. Gynecol Oncol. 2019. PMID: 31160070. doi:10.1016/j.ygyno.2019.05.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。